Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Partner Therapeutics

Partner Therapeutics
2017 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$60M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of drugs for oncology treatment. The company focuses on the development and commercialization of approved and late-stage therapies that improve treatment outcomes and reduce the total cost of care for cancer. Its development spans the entire range of cancer therapy from primary treatments to supportive care.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • One Marina Park Drive
  • Suite 900
  • Boston, MA 02210
  • United States

+1 (781) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Partner Therapeutics’s full profile, request a free trial.

Partner Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 01-Feb-2018 $60M 0000 0000 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Partner Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Partner Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 (000000 00 01-Feb-2018 000000000 00000 00 Buildings and Property 00000000 000000000000 00
To view this company’s complete investment and acquisition history, request access »

Partner Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Adams Street Partners PE/Buyout Minority 000 0000 000000 0
MidCap Financial Lender/Debt Provider Minority 000 0000 000000 0
Perceptive Advisors Hedge Fund Minority 000 0000 000000 0

Partner Therapeutics Executive Team (6)

Name Title Board
Seat
Contact
Info
Robert Mulroy Chief Executive Officer, Co-Founder & Chairman
William McClements Chief Financial & Operations Officer
Colleen Mockbee Chief Development Officer
Bob Bennett Chief Business Officer
Sarah Kurz Chief Commercial Officer
You’re viewing 5 of 6 executives. Get the full list »